Navigation Links
Personal Connections Drive Employee Participation For Changing Tomorrow Day at Astellas
Date:9/14/2012

NORTHBROOK, Ill., Sept. 14, 2012 /PRNewswire/ -- More than generosity of spirit drives employees at Astellas Pharma US, Inc. (Astellas Pharma US), a subsidiary of Tokyo-based Astellas Pharma Inc. (Astellas), to participate in the company's annual corporate social responsibility initiative, Changing Tomorrow Day, that wraps up today. A personal connection to the locations and a close tie to the company's mission of improving the lives of patients drive employees to volunteer.

For Mayumi Gaines of Astellas, the chance to volunteer for a project at the Ronald McDonald House in Maywood hit close to home. "My nine-year-old son was born with a craniofacial disorder called Crouzon Syndrome and had to undergo major surgery last year," said Gaines.  "We were lucky to live close to the hospital, but knowing how challenging it is for family members when their children are hospitalized motivated me to volunteer at the Ronald McDonald House."

Astellas employees like Gaines will be working on service projects throughout the United States, Canada and Brazil for Changing Tomorrow Day 2012. Points of Light, a non-profit organization, helped identify worthwhile sites throughout the country where employees will be teaching kids about health and wellness, beautifying buildings and grounds, painting health inspired murals, preparing and serving nutritious food and assembling hygiene kits for the homeless. In all, nearly 2,000 Astellas employees will take part in service projects throughout the Changing Tomorrow Day campaign, which is more than 80 percent of the company's total workforce in the Americas.

Masao Yoshida, President and CEO of Astellas, said he is gratified by the employees' response to Changing Tomorrow Day. "It is very important to us that we give back to our communities as much, if not more, than they give us. After all, these communities are our homes, too," he said.

In addition to asking f
'/>"/>

SOURCE Astellas Pharma US, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
2. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
3. AssureRx Health Launches Personalized Medicine Test for ADHD
4. Elevate Provides Remote Access to Personal Health Records Using MyMedicalRecords.com
5. EvergreenHealth Encourages Community to Use Free Microsoft Service to Store Personal Health Information for Emergencies
6. QIAGEN Achieves Personalized Healthcare Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer
7. ResearchMoz.US: Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift From Traditional Mass-Media Platforms Towards Personalization via Online and Social Media- Market Research Report
8. Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media
9. National Personal Injury Lawyers, TorHoerman Law, Provides Yaz Lawsuit Update
10. University of Pennsylvania and Novartis Form Alliance to Expand Use of Personalized T Cell Therapy for Cancer Patients
11. Four Million People Choose Connectivity and Convenience with Kaiser Permanentes Personal Health Record
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Calif. , July 10, 2014 Integrated ... leader in advanced memory and analog IC solutions, today ... on Thursday, July 24, 2014, at 7:00 a.m. Pacific ... financial results for the fiscal 2014 third quarter ended ... call via telephone, dial 1-888-556-4997 before 6:50 a.m. Pacific ...
(Date:7/10/2014)... , July 10, 2014  BC Technical, the largest ... MiE America , Inc., a leading provider of Siemens ... a long-term agreement naming BC Technical as the authorized ... MiE and BC Technical announced today that ... establish BC Technical as the service and systems provider ...
(Date:7/10/2014)... 10, 2014  Decision Resources Group finds that ... (ID) specialists are willing to prescribe Durata,s Dalvance ... use as OPAT, approximately two-thirds of the respondents ... their hospital inpatients. However, our findings indicate that ... initiated on OPAT following hospital discharge, and most ...
Breaking Medicine Technology:BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3
... for Vidaza versus 26.2 for ... patients on Vidaza compared to ... compared to conventional ... Only epigenetic modifier to show survival benefit in cancer Stratified log-rank p-value = ...
... trial of AKIi-5 as the first human clinical study ... involving the systemic ... Quark Pharmaceuticals, Inc., a,clinical-stage biopharmaceutical company focused on discovering ... positive results from preclinical efficacy studies for its,proprietary systemically-administered, ...
Cached Medicine Technology:Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS) 2Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS) 3Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS) 4Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS) 5Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS) 6Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS) 7Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS) 8Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF) 2Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF) 3Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF) 4
(Date:7/11/2014)... Cancer researchers in Slovenia say genetic ... on how patients respond to treatment with pemetrexed (Alimta), ... has the full story. Click here to read ... University of Ljubljana and the Ljubljana Institute of Oncology ... types of polymorphisms. They found that patients with genetic ...
(Date:7/11/2014)... 11, 2014 Anterior Cruciate Ligament (ACL) ... the type of material used to create a new ... game, say researchers presenting their work today at the ... Medicine ( AOSSM ). , “Our study ... (tissue harvested from a donor) fail more frequently than ...
(Date:7/11/2014)... Woodland Hills permanent teeth in one day ... Art Institute in Woodland Hills and Oxnard, Calif., will speak ... Del Rey, Calif. , The award-winning prosthodontist, international speaker ... teeth in one day dental procedure at 1:30 p.m. Friday, ... developed 15 years ago, Dr. Jivraj said. Getting new teeth ...
(Date:7/11/2014)... 2014 BellasDress, the experienced dressmaker in ... online suppliers when it comes to beach wedding ... collection of beach wedding outfits in its online shop. ... elegant outfits. , BellasDress has been considered as ... According to the company’s senior spokesman, BellasDress provides superb ...
(Date:7/11/2014)... The International Concussion Organization is hosting its 1st ... in Times Square, New York on July 17th ... that is plaguing athletes in nearly all sports ... Symposium gathers more than a dozen internationally prominent ... legal scholars for engaging and uniquely relevant scientific ...
Breaking Medicine News(10 mins):Health News:New Research Finds Genetic Variables Impact Chemotherapy Response, According to Surviving Mesothelioma 2Health News:ACL Reconstructions May Last Longer With Autografts 2Health News:Woodland Hills Dental Expert Speaking at Nobel Biocare World Symposium in One Week 2Health News:Woodland Hills Dental Expert Speaking at Nobel Biocare World Symposium in One Week 3Health News:Woodland Hills Dental Expert Speaking at Nobel Biocare World Symposium in One Week 4Health News:Woodland Hills Dental Expert Speaking at Nobel Biocare World Symposium in One Week 5Health News:BellasDress Emerges As Popular Online Supplier Of 2014 Beach Wedding Dresses 2Health News:The International Concussion Organization 501(c)(3) hosts its 1st Annual Concussion Symposium at the Best Buy Theater in Time Square, NYC, July 17th, 2014. 2
... Ala., May 27 Leading fitness social network and tracking ... name to DailyBurn , effective immediately.In just ... community of more than 125,000 members, who have, depending on ... gained an average of 5.75 lbs of muscle using DailyBurn,s ...
... Integrated Delivery Systems, Telehealth Pioneer ATI is Transforming Care for High-Risk, ... Care 24/7/365 , ... Irvine, Calif., and Minneapolis, Minn. ... now, Entrepreneur magazine named American TeleCare, Inc. (ATI) as one of ...
... HabitsMORRISTOWN, N.J., May 27 Whether it,s "powdering your nose" ... significant amount of time in the bathroom. According to ... minutes each day in the bathroom -- that adds up ... than double that of the average vacation trip(1). And ...
... ignite09 to Improve Health Outcomes and Lower CostsWASHINGTON, ... Consumerism, the American Benefits Council and Hewitt Associates ... are bringing together leaders in innovation from across ... the convergence of behavioral economics and healthcare. ...
... Longer term follow-up indicates modest efficacy in primary ... 27 Ceregene, Inc. today reported additional clinical ... of CERE-120 in 58 patients with advanced Parkinson,s ... deliver the neurotrophic factor, neurturin, to Parkinson,s disease ...
... Practical Insights on Physician Engagement, Career SuccessSCOTTSDALE, Ariz., ... Corporation, whose Fusionfx solution suite aggregates ... single, clinically relevant views of patient information, today ... papers documenting the increasing involvement of healthcare chief ...
Cached Medicine News:Health News:Gyminee Raises 525K and Relaunches as DailyBurn 2Health News:Entrepreneur Magazine Names American TeleCare, Inc. (ATI) One of the Nation's 100 Brilliant Companies to Watch in 10 Hot Industries 2Health News:Entrepreneur Magazine Names American TeleCare, Inc. (ATI) One of the Nation's 100 Brilliant Companies to Watch in 10 Hot Industries 3Health News:Where Do Americans Spend More Than a Week Each Year? Not on Vacation... 2Health News:Where Do Americans Spend More Than a Week Each Year? Not on Vacation... 3Health News:Where Do Americans Spend More Than a Week Each Year? Not on Vacation... 4Health News:Where Do Americans Spend More Than a Week Each Year? Not on Vacation... 5Health News:Key Stakeholders Convene Capitol Hill Symposium To Advance Convergence of Behavioral Economics and Healthcare 2Health News:Key Stakeholders Convene Capitol Hill Symposium To Advance Convergence of Behavioral Economics and Healthcare 3Health News:Key Stakeholders Convene Capitol Hill Symposium To Advance Convergence of Behavioral Economics and Healthcare 4Health News:Key Stakeholders Convene Capitol Hill Symposium To Advance Convergence of Behavioral Economics and Healthcare 5Health News:Ceregene Presents Additional Clinical Data from Phase 2 Trial of CERE-120 for Parkinson's Disease 2Health News:Ceregene Presents Additional Clinical Data from Phase 2 Trial of CERE-120 for Parkinson's Disease 3Health News:Ceregene Presents Additional Clinical Data from Phase 2 Trial of CERE-120 for Parkinson's Disease 4Health News:Ceregene Presents Additional Clinical Data from Phase 2 Trial of CERE-120 for Parkinson's Disease 5Health News:Carefx's Newest White Paper Illuminates Healthcare CIOs' Growing Role in Operations, Strategic Thinking and IT Project Decision Making 2Health News:Carefx's Newest White Paper Illuminates Healthcare CIOs' Growing Role in Operations, Strategic Thinking and IT Project Decision Making 3
The Aaron 800-EU is designed and engineered to be the most reliable and durable desiccator available today....
Sabre 180 is a powerful niche generator....
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator....
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator....
Medicine Products: